← Back to headlines
BridgeBio Stock Jumps 13% Following Price Target Upgrade
BridgeBio (BBIO) shares surged by 13% after receiving a double-digit price target upgrade, indicating increased investor confidence in the company's financial outlook.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
